Guardant Health
356 hedge funds and large institutions have $6.12B invested in Guardant Health in 2022 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 112 increasing their positions, 136 reducing their positions, and 84 closing their positions.
209% more call options, than puts
Call options by funds: $105M | Put options by funds: $34.1M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.12% less ownership
Funds ownership: 90.94% → 90.82% (-0.12%)
10% less funds holding
Funds holding: 396 → 356 (-40)
18% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 136
34% less capital invested
Capital invested by funds: $9.24B → $6.12B (-$3.12B)
43% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 84
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$144M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$141M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$84.1M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$50.5M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$32.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$268M |
| 2 |
FAM
Fred Alger Management
New York
|
-$94.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$85.4M |
| 4 |
DCP
D1 Capital Partners
New York
|
-$47.9M |
| 5 |
Chevy Chase Trust
Bethesda,
Maryland
|
-$37.2M |
GH Hedge Fund Activity: Q1 2022 in Review
356 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q1 2022, worth a combined $6.12B — down 34% from $9.24B a quarter earlier.
Sellers outnumbered buyers: 84 funds closed out of GH and 48 opened new positions — a net loss of 36 holders — while 136 trimmed existing stakes and 112 added.
The largest buyer was Capital International Investors, adding an estimated $144M. The largest seller was Capital Research Global Investors, cutting an estimated $268M.
- 356 institutional investors held Guardant Health (GH) as of Q1 2022, down from 396 in Q4 2021.
- Funds reported $6.12B of Guardant Health stock for Q1 2022, down 34% quarter-over-quarter.
- 48 funds opened new Guardant Health positions in Q1 2022 and 84 closed out, a net change of -36 holders.
- The largest Guardant Health buyer in Q1 2022 was Capital International Investors, an estimated $144M added.
- The largest Guardant Health seller in Q1 2022 was Capital Research Global Investors, an estimated $268M sold.
Based on aggregated 13F filings for Q1 2022.